文献速递神经肿瘤

定量多模态磁共振成像作为复发低级别胶质瘤患者的无创预后工具

Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.
PubMed 文献 · J Neurooncol · 2017-01-25

研究假设磁共振数据参数与复发低级别胶质瘤患者的无进展生存期相关,分析了解剖成像、弥散加权成像和1H磁共振波谱成像数据。弥散和波谱成像指标在全人群及星形细胞瘤中呈现强预后能力,但在少突胶质细胞瘤中效能更有限。结果表明多参数成像数据可作为无创评估预后的手段,并可能有助于制定个体化治疗方案。

要点

  • 弥散和波谱成像指标在全人群及星形细胞瘤中呈现强预后能力。
  • 弥散和波谱成像指标在少突胶质细胞瘤中预后效能更有限。
  • 多参数成像数据可能作为无创评估预后的手段。

核心结论

  • 多参数成像数据可能作为无创评估预后的手段,并可能有助于为复发低级别胶质瘤患者制定个体化治疗方案。

研究设计与样本

  • 研究假设磁共振数据参数与复发低级别胶质瘤患者的无进展生存期相关,分析了解剖成像、弥散加权成像和1H磁共振波谱成像数据。

主要发现

  • 弥散和波谱成像获得的指标在全人群以及限制于星形细胞瘤时均呈现强预后能力,但在少突胶质细胞瘤中效能更有限。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low-grade gliomas can vary widely in disease course and therefore patient outcome. While current characterization relies on both histological and molecular analysis of tissue resected during surgery, there remains high variability within glioma subtypes in terms of response to treatment and outcome. In this study we hypothesized that parameters obtained from magnetic resonance data would be associated with progression-free survival for patients with recurrent low-grade glioma. The values considered were derived from the analysis of anatomic imaging, diffusion weighted imaging, and 1H magnetic resonance spectroscopic imaging data. Metrics obtained from diffusion and spectroscopic imaging presented strong prognostic capability within the entire population as well as when restricted to astrocytomas, but demonstrated more limited efficacy in the oligodendrogliomas. The results indicate that multi-parametric imaging data may be applied as a non-invasive means of assessing prognosis and may contribute to developing personalized treatment plans for patients with recurrent low-grade glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Neill E, Luks T, Dayal M, et al. Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma. J Neurooncol. 2017. PMID: 28124178. doi:10.1007/s11060-016-2355-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。